XML 37 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Statements of Operations - USD ($)
12 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2017
REVENUES      
Patient fee revenue, net of contractual allowances and discounts $ 24,207,536 $ 39,165,413 $ 36,400,600
Provision for bad debts for patient fee (17,896,528) (16,171,434)
Patient fee revenue - net 24,207,536 21,268,885 20,229,166
Product sales - net 1,751,221 602,541 1,572,148
Service and repair fees - net 8,152,173 9,124,728 9,537,040
Service and repair fees - related parties - net 110,000 110,000 110,000
Management and other fees - net 43,617,093 41,422,958 38,361,514
Management and other fees - related party medical practices - net 9,354,864 8,986,882 8,226,718
Total Revenues - Net 87,192,887 81,515,994 78,036,586
COSTS AND EXPENSES      
Costs related to product sales 778,734 751,221 931,501
Costs related to service and repair fees 3,009,097 3,212,527 2,996,736
Costs related to service and repair fees -related parties 40,603 38,728 34,564
Costs related to patient fee revenue 10,789,308 10,256,951 8,987,673
Costs related to management and other fees 23,419,796 22,778,202 20,828,581
Costs related to management and other fees - related medical practices 5,947,055 4,913,141 4,273,370
Research and development 1,812,347 1,755,747 1,480,670
Selling, general and administrative is inclusive of compensatory element of stock issuances 19,261,755 18,125,266 19,407,411
Total Costs and Expenses 65,058,695 61,831,783 58,940,506
INCOME      
Income from Operations 22,134,192 19,684,211 19,096,080
Other Income and (Expenses):      
Interest expense (98,636) (160,074) 28,299
Investment income 482,573 262,569 193,141
Other income (expense)- net 1,065 (4,271) (1,156)
Income before (provision) benefit for income taxes and noncontrolling interests 22,519,194 19,782,435 19,316,364
(Provision) benefit for income taxes 2,005,520 (5,669,750) (4,362,434)
Net Income 20,513,674 25,452,185 23,678,798
Net Income - Noncontrolling Interests (5,196,543) (4,221,383) (4,058,177)
Net Income - Attributable to FONAR 15,317,131 21,230,802 19,620,621
Common Shares      
Other Income and (Expenses):      
Net Income - Attributable to FONAR $ 14,366,798 $ 19,899,823 $ 18,390,586
Basic Net Income Per Common Share $ 2.26 $ 3.16 $ 2.98
Diluted Net Income Per Common Share $ 2.22 $ 3.1 $ 2.92
Weighted Average Basic Shares Outstanding - Common Stockholders 6,354,103 6,287,510 6,161,599
Weighted Average Diluted Shares Outstanding - Common Stockholders 6,481,607 6,415,014 6,289,103
Class A Non Voting Preferred Stock      
Other Income and (Expenses):      
Net Income - Attributable to FONAR $ 708,302 $ 992,005 $ 916,769
Class C Common Stock      
Other Income and (Expenses):      
Net Income - Attributable to FONAR $ 242,031 $ 338,974 $ 313,266
Basic Net Income Per Common Share $ 0.63 $ 0.89 $ 0.82
Diluted Net Income Per Common Share $ 0.63 $ 0.89 $ 0.82
Weighted Average Basic Shares Outstanding - Common Stockholders 382,513 382,513 382,513
Weighted Average Diluted Shares Outstanding - Common Stockholders 382,513 382,513 382,513